| Zacks Company Profile for LakeShore Biopharma Co., Ltd. (LSBCF : OTC) |
|
|
| |
| • Company Description |
| LakeShore Biopharma is a biopharmaceutical company. It involved in discovering, developing, manufacturing and delivering vaccines and therapeutic biologics for infectious diseases and cancer. The company operates primarily in China, the United States, Singapore and the Philippines. LakeShore Biopharma, formerly known as YS Biopharma, is based in GAITHERSBURG, Md.
Number of Employees: |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.80 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 88,220 shares |
| Shares Outstanding: 20.77 (millions) |
| Market Capitalization: $16.61 (millions) |
| Beta: 0.54 |
| 52 Week High: $4.37 |
| 52 Week Low: $0.30 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-0.62% |
-1.21% |
| 12 Week |
-25.93% |
-29.81% |
| Year To Date |
-76.88% |
-79.57% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
BUILDING NO. 2 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK
-
DAXING DISTRICT BEIJING,F4 102629
CHN |
ph: 010-89202086
fax: - |
ir@lakeshorebio.com |
http://www.ysbiopharm.com |
|
|
| |
| • General Corporate Information |
Officers
Xu Wang - Chief Executive Officer and Director
Pierson Yue Pan - Chairman of the Board and Director
Hui Shao - Vice Chairman of the Board; President and Director
Rachel Yu - Chief Financial Officer
Adam Zhao - Director
|
|
Peer Information
LakeShore Biopharma Co., Ltd. (CORR.)
LakeShore Biopharma Co., Ltd. (RSPI)
LakeShore Biopharma Co., Ltd. (CGXP)
LakeShore Biopharma Co., Ltd. (BGEN)
LakeShore Biopharma Co., Ltd. (GTBP)
LakeShore Biopharma Co., Ltd. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: G9845F208
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding: 20.77
Most Recent Split Date: 10.00 (0.10:1)
Beta: 0.54
Market Capitalization: $16.61 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: - |
|
|
|
| |
